Myriad Genetics Inc (NASDAQ:MYGN)

19.27
Delayed Data
As of 3:59pm ET
 -1.10 / -5.40%
Today’s Change
13.92
Today|||52-Week Range
28.18
+32.80%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close20.37
Today’s open19.72
Day’s range19.15 - 19.83
Volume15,772
Average volume (3 months)671,445
Market cap$1.7B
Data as of 3:59pm ET, 01/30/2023

Growth & Valuation

Earnings growth (last year)+87.01%
Earnings growth (this year)-2,066.66%
Earnings growth (next 5 years)-10.28%
Revenue growth (last year)+8.14%
P/E ratioNM
Price/Sales3.12
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...+0.01+0.01%
VCYTVeracyte Inc-1.46-5.61%
----
CLDXCelldex Therapeutics...-2.09-4.52%
Data as of 4:00pm ET, 01/30/2023

Financials

Next reporting dateFebruary 23, 2023
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$690.6M
Annual profit (last year)-$27.2M
Net profit margin-3.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts